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Background: Further research on effective interventions for patients with peristent Medically Unexplained Physical
Symptoms (MUPS) in general practice is needed. Prevalence estimates of such patients are conflicting, and other
descriptive knowledge is needed for development and evaluation of effective future interventions. In this study,
we aimed to estimate the consultation prevalence of patients with persistent MUPS in general practice, including
patients’ characteristics and symptom pattern, employment status and use of social benefits, and the general
practitioners’ (GPs) management strategy.
Method: During a four-week period the participating Norwegian GPs (n = 84) registered all consultations with
patients who met a strict definition of MUPS (>3 months duration and function loss), using a questionnaire with
simple tick-off questions. Analyses were performed with descriptive statistics for all variables and split analysis on
gender and age.
Results: The GPs registered 526 patients among their total of 17 688 consultations, giving a consultation
prevalence of persistent MUPS of 3%. The mean age of patients was 46 years, and 399 (76%) were women. The
most frequent group of symptoms was musculoskeletal problems, followed by asthenia/fatigue. There was no
significant gender difference in symptom pattern. Almost half of the patients were currently working (45%),
significantly more men. The major GP management strategy was supportive counseling.
Conclusion: A consultation prevalence rate of 3% implies that patients with persistent MUPS are common in
general practice. Our study disclosed heterogeneity among the patients such as differences in employment status,
which emphasizes the importance of personalized focus rather than unsubstantiated stereotyping of “MUPS
patients” as a group.
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Medically Unexplained Physical Symptoms (MUPS) cap-
tures conditions characterized by symptoms without corre-
sponding objective findings [1], such as asthenia, low back
pain, fibromyalgia, irritable bowel syndrome, or chronic fa-
tigue syndrome. Drawing upon our clinical experience, we
distinguish between everyday and self-limiting complaints* Correspondence: aase.aamland@gmail.com
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unless otherwise stated.as compared to persistent MUPS, with long-lasting symp-
tom and loss of function.
Although the term is debated [2-4], we find its use ap-
propriate for clinical and research purposes. First, there
are substantial similarities and co-morbidity across differ-
ent MUPS disorders [5,6], indicating possible common
underlying symptom mechanisms [7]. Second, several
studies claim similar treatment to be effective across differ-
ent MUPS disorders [8]. Third, patients with MUPS have
been associated with high costs, both direct (health care
use) and indirect costs (productivity loss due to sickness
absence) [9].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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practice is conflicting, with prevalence rates ranging
from 1.1 to 33% [1,10-17]. This is probably due to differ-
ent or imprecise definitions of the condition, or different
data sources for measurement. An often-reported figure
is 15% [18], while Steinbrecher et al. report more than
two-thirds of all consultations to be related to MUPS
[19]. A recent Cochrane review calls for more knowledge
about the use of social benefits among patient with MUPS
[20]. Consultation prevalence, or the proportion of consul-
tations with a certain condition, is an adequate measure
for health care utilization related to different health prob-
lems in general practice, for instance when estimating dir-
ect costs of MUPS [9].
Effective interventions for patients with persistent MUPS
in general practice are yet to be established, but should be
based on treatment studies where more descriptive know-
ledge of the patients is included. We therefore conducted
a study in a naturalistic GP-setting to estimate the con-
sultation prevalence and describe symptom pattern of
patients with persistent MUPS in Norwegian general
practice. We also wanted to describe these patients’ em-
ployment status and use of social benefits, and the GPs
management strategy.
Method
In planning, implementation and reporting we used the
STROBE check list for cross-sectional studies [21].
Study setting and design
Norway has 5, 05 million inhabitants and 4 189 GPs. A
list system includes 99.5% of the population and con-
nects every Norwegian citizen to a specific GP. The GPs
issue 80% of all sickness certificates [22]. Health care is
mostly publicly financed, with a fixed amount of maximum
personal charge per year for the patient. Vest-Agder county
has approximately 180 000 inhabitants and 160 GPs located
in 44 different practices. It has a mix of rural and urban
areas, and covers a range of socioeconomic status among
the inhabitants.
In October 2012 all GPs in this county were invited by
postal letter to participate in our multi-practice cross-
sectional study, after piloting in a practice with 13 GPs.
The GPs were asked to register all patients who met a
strict definition of persistent MUPS (see below) attending
during a four-week period. We defined the consultation
prevalence as the number of consultations with patients
with MUPS related to the total number of consultations
across the study period. The GPs received invitation-letter
and then reminder e-mails before, right after study-start
and midway in the registration period. AA promoted the
study through meetings with the GPs, either duringlunch-visits or in supervised peer groups. One week after
the registration period, all non- responders were contacted
with a reminder letter, e-mail, SMS or telephone.Case definition and questionnaire
For the purpose of this study, we defined persistent
MUPS as “physical symptoms with no identified organic
cause, lasting for at least three months and leading to a
loss of function”. Loss of function was explained as sickness
absence or disability, or withdrawal from social activities
like sports, social events or other leisure activities. In case
of co-morbid diseases, the unexplained symptoms should
outweigh function loss caused by medically explained
symptoms. Our case definition was carefully presented
in the invitation letter, e-mails and personal meetings
with the GPs. Patients ≥ 18 years were included.
The GPs were asked to register data from every eligible
patient on a one-page form with simple tick-off questions
during a four-week period. The registration form, which was
completed in less than three minutes (see Additional file 1),
included relevant demographic information, symptom pat-
tern (duration and localization), work participation and
the GPs management strategy in the actual consultation.Statistics
The data were analyzed using IBM SPSS version 20 for
Windows with descriptive statistics for all variables and
split analysis on gender and age. We used independent-
samples-t-tests for comparing means on continuous
variables for two different groups of participants, and
Chi-square test for independence to explore the relation-
ship between categorical variables. Possible relation-
ship between number of registered patients and different
GP-characteristics were investigated using simple bivariate
correlation. The level of statistical significance was set to
p < 0.05.Results
Participating GPs
The response rate was 53% (84/160). The invited GPs
were representative for Norwegian GPs, although with
an excess of men and GP specialists (Table 1). Participat-
ing male GPs were significantly older (p = 0.011), and
had worked more years in general practice than the fe-
males (p = 0.002) (Table 2). There was a variation in the
number of recorded consultations with patients with per-
sistent MUPS (MUPS consultations) per GP (range 0–26,
mean = 6.38, SD = 4.97). No significant associations were
found between number of recorded MUPS consultations
and gender, age, specialist status, years in practice, or the
total number of consultations during the registration
period among the GPs (Table 2).
Table 1 Characteristics of all Norwegian GPs, GPs in
Vest-Agder and the participating GPs
Norway Vest-Agder Participants
n = 4 189 n = 160 n = 84
Age, mean 48.5 y 48.1 y 48.0 y
Women 36.5% 33.5% 29.8%
Mean number of
patients listed per doctor
1 164 1 083 1 107
Specialty attainment 55.0% 62.0% 72.6%
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patients
The GPs registrated 526 MUPS consultations out of a
total of 17 688 consultations, which gave a consultation
prevalence rate of 3%. Of these were 399 (75.9%) with fe-
male patients. The educational level among the patients
did not differ from the distribution in the population in
the county as a whole [23]. 234 (44.7%) of the patients
were working, significantly more men (p = 0.047) (Table 3).
Among the 289 not working, 91 (31.5%) were on sick
leave, 119 (41.2%) had a disability pension, and 76 (26.3%)
had other social benefits, mostly work assessment allow-
ance. There was no significant gender difference in pa-
tients’ age, education level or duration of symptoms
(Table 4), or symptom pattern (Table 3). Musculoskeletal
pain and asthenia/fatigue were predominant symptoms,
with 68.1% and 57.0% of all patients respectively. Head-
ache or dizziness was reported by 31.9% of the patients
and gastrointestinal symptoms by 20.5%.GPs management
The majority of the GPs reported that they had offered
supportive counseling in the actual MUPS consultations.
Medication was prescribed in 21.6% of the consultations.
About 20% of the consultations included lab tests or referrals.
There were no significant gender differences in GPs man-
agement strategy (Table 3).Table 2 Demographics of the participating GPs (n = 84; men 5
persistent MUPS among all consultations during the four-wee
Total
Mean (SD) Range Mean
Age* 48.0 (11.37) 26-68 49.9
Years in practice* 17.8 (12.15) 0-42 20.3
List length 1107 (340.0) 370-2496 1126
MUPS-patientsˡ 6.38 (4.97) 0-26 6.32
N consultations 210.33 (82.55) 48-394 218.8
*Difference between genders is significant at the 0.05 level.
ˡAssociation between number of patients with persistent MUPS and total consultatiDiscussion
Summary
This study presents for the first time cross-sectional de-
scriptive data on consultations with patients with persist-
ent MUPS in Norwegian general practice. A consultation
prevalence rate of 3% suggests that patients with persist-
ent MUPS are common when compared to other reasons
for encounter. Musculoskeletal symptoms were the most
frequent symptom pattern, followed by asthenia/fatigue.
Almost 45% of the patients were working. About 2/3 of
the GPs offered supportive counseling at the actual
consultation.
Strengths and limitations
Our study is strengthened by the naturalistic setting and
the rigorous case definition, which was carefully de-
scribed, also through a clinical vignette during personal
meetings. Our case definition resembles definitions used
in previous research [12,13,15]. The prevalence in this
study is on MUPS patients as perceived by Norwegian
GPs and not a prevalence of MUPS in the general pub-
lic, and due to the study design one patient may have
been registered several times, which may influence the
results. We believe however this not to be very likely
and does not affect the prevalence rate, as this is still a
prevalence of MUPS consultations in general practice.
Our design did not allow for inter-rater-reliability
checks of the GPs’ assessments. As mean duration of a
GP-patient relationship in Norway is 7.7 years [24], we
may assume GPs to easily recognize eligible patients
due to their knowledge about their patients. Data collec-
tion based on digital patient records or interviews may
represent larger sources of bias, due to lack of a specific
MUPS-diagnosis, incomplete medical records or inter-
viewer’s lack of personal knowledge of the actual
patients.
Sample bias was reduced through an overall represen-
tative sample of GPs-, indicating that the results may be
generalised to a comparable setting. However, more par-
ticipating male GPs may underestimate the consultation9, women 25), and their proportion of patients with
k registration period
Men Women
(SD) Range Mean (SD) Range
(11.63) 26-68 43.5 (9.49) 26-60
(12.27) 0-42 11.8 (9.98) 0-32
(364.2) 370-2496 1061 (277.4) 460-1450
(5.39) 0-26 6.52 (3.91) 0-15
(77.8) 57-363 190.4 (91.40) 48-394
ons at the level of 0.01 (pearson p = 0.001, spearman, p = 0.003).
Table 3 Patients with persistent MUPS (n = 526, men 125,
women 399)
All Men Women
Symptom pattern, n (%)
Gastrointestinal 108 (20.5) 26 (20.5) 82 (20.6)
Musculoskeletal 358 (68.1) 78 (61.4) 280 (70.2)
Headache/dizziness 168 (31.9) 36 (28.3) 132 (33.1)
Asthenia/fatigue 300 (57.0) 72 (56.7) 228 (57.1)
Others 41 (7.8) 10 (7.9) 31 (7.8)
Work status, n (%)
Working* 234 (44.7) 67 (52.8) 167 (42.2)
Not working
Sick leave 91 (31.5) 18 (30.0) 73 (31.9)
Disability pension 119 (41.2) 25 (41.7) 94 (41.0)
Other 76 (26.3) 18 (30.0) 58 (25.3)
GPs management, n (%)
Supportive counceling 333 (63.7) 83 (65.4) 250 (63.1)
Physical examination 195 (32.3) 50 (31.4) 145 (36.6)
Prescriptions 124 (23.7) 27 (21.3) 97 (24.5)
Blood test 113 (21.6) 20 (15.7) 93 (23.5)
Referral 93 (17.8) 24 (18.9) 69 (17.4)
Social security certificates 106 (20.3) 25 (19.7) 81 (20.5)
Others 41 (7.8) 11 (8.7) 30 (7.6)
Symptom localization, work status and GPs management in numbers and percent.
*Difference between genders is significant at the 0.05 level.
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and, due to gender effects on communication, they may
see more patients with MUPS [25]. GP based prevalence
estimates are found to be consequently underestimated









Primary school 131 (25.5)
Highschool 249 (48.6)
College/university 133 (25.9)
Duration of MUPS (n, %)
<1 year 73 (14.0)
1-5 years 161 (30.9)
> 5 years 287 (55.1)
Age, level of education and symptom duration.of less clinical significance, which we did not intend to
include in this study.
A response rate of 53% is modest, although higher
than other surveys of GPs on MUPS [27,28]. Further-
more, our sample seemed to be fairly representative for
Norwegian GPs.
Possible source of information bias may be due to in-
complete recordings due to GPs busy workday [29,30]
resulting in ignored eligible patients (consultation preva-
lence underestimated), or a non-compliant attitude to
the actual instruction due to an eager to participate be-
cause of professional relationships with the first author
(skewing possible for both directions). The GPs in the
area received various reminders and information about
the study. How this may have influenced the registration
is unknown [31]. On the other hand, personal and exten-
sive study information may have raised the actual quality
of the collected data.
Only 32% of the patients in our sample were on sick
leave. This finding seems to oppose previous research
[32] by suggesting that previous assumptions of high
level of disability among patients with persistent MUPS
needs revision. However, as loss of function was a criter-
ion for eligibility in the study, we can only assume that
that these patients met this criterion otherwise than be-
ing out of work.
Comparison with existing literature
A consultation prevalence rate of 3% suggests that pa-
tients with persistent MUPS are common in general
practice when compared to other frequently occurring
conditions like hypertension, atrial fibrillation, diabetes
mellitus, and depression, each accounting for 1.3-4.9% of
the consultations in Norwegian general practice [33]. A526) in numbers and percent
Men Women
127 (24.1%) 399 (75.9%)
45.74 (SD = 14.09) 46.23 (SD = 13.88)
43 (34.7) 139 (35.1)
70 (56.6) 221 (55.8)
11 (8.7) 36 (9.1)
30 (24.4) 101 (25.9)
67 (54.5) 182 (46.7)
26 (21.1) 107 (27.4)
25 (20.0) 48 (12.1)
39 (31.2) 122 (30.8)
61 (48.8) 226 (57.1)
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care in US [12] presented exactly the same consultation
prevalence for persistent MUPS by use of a similar case
definition, and a Dutch study from primary care found a
prevalence of 2.45% on persistent MUPS [11].
More women (76%) than men in our sample suffered
from MUPS, consistent with prior studies [34]. However,
we should keep in mind that doctors tend to categorize
female patients more easily as somatizers than male ones
[35] and that this may be the same for patients with MUPS
as we do not see persistent MUPS as synonymous with
‘severe somatization disorder’ [36].
In contrast to findings from a similar study we found
linearity between number of patients with persistent
MUPS and total number of consultations at the individ-
ual GPs [12]. Musculoskeletal symptoms were the most
frequent MUPS symptom pattern in our study, followed
by asthenia/fatigue. These findings diverge from a re-
cent study where asthenia/fatigue was leading among
patients with persistent MUPS [34]. However use of dif-
ferent case definitions may contribute to this difference,
and with knowledge of substantial co-occurrence for these
symptoms, this finding may be of less clinical importance.
An important overall finding challenges the stereotypes
of patients with persistent MUPS. In our study, this group
of patients is heterogenous - a quarter are men, a quarter
has higher education, a third is below age 40, and nearly
half of them work. This highlights the need to refrain from
unsubstantiated stereotyping of “MUPS-patients”.
Our finding of a scarce prescription rate complies with
recommendations that medication should play a minor
role in medical management of MUPS [37,38]. Our case
definition implied prior appropriate diagnostic evaluations,
but still we found that one out of five patients received fur-
ther referrals. This may illustrate GPs feeling of shortcom-
ing in managing these patients, and a lack of knowledge of
what these patients’ actual want and need [39,40]. Further-
more, it may illustrate a limited awareness among the GPs
about potentially iatrogenic harms trough additional inter-
ventions [41]. However, actual lab test and referrals in the
registered MUPS consultations may represent adequate
management of other co-existing diseases or presentation
of new symptoms, which may represent new disease.
Levels of supportive counseling at the GP encounter
will probably vary according to structure of health care
system. In a study from US, 37% were referred to different
mental health care center [12], reflecting possible differ-
ences in therapeutic cultures. It seems like Norwegians
GPs more often provide supportive care themselves rather
referring to secondary care.
Conclusion
This study reveals that consultations with patients with
persistent MUPS are common in general practice. Theseconsultations represent a heterogeneous group of patients,
which illustrate possible needs for modifications of stereo-
typing upon these patients. A continuous focus on GPs
knowledge and management skills of MUPS is important,
as GPs have a major role in caring for these patients. More
research on effective interventions, based on know-




Only the individual GP knew the identity of the patients
and all personal data were anonymous. Therefore, neither
The Regional Committee for Ethics in Medical Research
nor the Norwegian Social Science Data Services (NSD)
regarded the study to be within their mandatory (Reference
number 31527/3/AMS).
Keypoint
 Patients with persistent MUPS account for 3% of
consultations in Norwegian general practice;
 Musculoskeletal symptoms were most frequent,
followed by asthenia/fatigue;
 45% of patients with persistent MUPS were
currently working, of these significantly more men;
 A major GP-management strategy was supportive
counseling. GPs need tools to identify and provide
adequate health care for patients with persistent
MUPS.
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